Design and synthesis of 3-[(7-chloro-1-oxidoquinolin-4-ylamino)alkyl]-1,3-thiazolidin-4-ones as antimalarial agents

References

• Wiesner J, Ortmann R, Jomaa H, Schlitzer M. New antimalarial drugs. Angew Chem Int Ed Engl 2003;42:5274–5293.
   PubMed Web of Science ®Google Scholar
• O’Neill PM, Ward SA, Berry NG, Jeyadevan JP, Biagini GA, Asadollaly E et al. A medicinal chemistry perspective on 4-aminoquinoline antimalarial drugs. Curr Top Med Chem 2006;6:479–507.
   PubMed Web of Science ®Google Scholar
• Stocks PA, Raynes KJ, Bray PG, Park BK, O’Neill PM, Ward SA. Novel short chain chloroquine analogues retain activity against chloroquine resistant K1 Plasmodium falciparum. J Med Chem 2002;45:4975–4983.
   PubMed Web of Science ®Google Scholar
• Ridley RG, Hofheinz W, Matile H, Jaquet C, Dorn A, Masciadri R et al. 4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob Agents Chemother 1996;40:1846–1854.
   PubMed Web of Science ®Google Scholar
• Dorn A, Stoffel R, Matile H, Bubendorf A, Ridley RG. Malarial haemozoin/beta-haematin supports haem polymerization in the absence of protein. Nature 1995;374:269–271.
   PubMed Web of Science ®Google Scholar
• Egan TJ, Marques HM. The Role of Haem in the Activity of Chloroquine and Related Antimalarial Drugs. Coord Chem Rev 1999;190–192:493–517.
   Google Scholar
• Pandey AV, Bisht H, Babbarwal VK, Srivastava J, Pandey KC, Chauhan VS. Mechanism of malarial haem detoxification inhibition by chloroquine. Biochem J 2001;355:333–338.
   PubMedGoogle Scholar
• Ray S, Madrid PB, Catz P, LeValley SE, Furniss MJ, Rausch LL et al. Development of a new generation of 4-aminoquinoline antimalarial compounds using predictive pharmacokinetic and toxicology models. J Med Chem 2010;53:3685–3695.
   PubMedGoogle Scholar
• Iwaniuk DP, Whetmore ED, Rosa N, Ekoue-Kovi K, Alumasa J, de Dios AC et al. Synthesis and antimalarial activity of new chloroquine analogues carrying a multifunctional linear side chain. Bioorg Med Chem 2009;17:6560–6566.
   PubMed Web of Science ®Google Scholar
• Omodeo-Salè F, Cortelezzi L, Basilico N, Casagrande M, Sparatore A, Taramelli D. Novel antimalarial aminoquinolines: heme binding and effects on normal or Plasmodium falciparum-parasitized human erythrocytes. Antimicrob Agents Chemother 2009;53:4339–4344.
   PubMedGoogle Scholar
• Yearick K, Ekoue-Kovi K, Iwaniuk DP, Natarajan JK, Alumasa J, de Dios AC et al. Overcoming drug resistance to heme-targeted antimalarials by systematic side chain variation of 7-chloro-4-aminoquinolines. J Med Chem 2008;51:1995–1998.
   PubMed Web of Science ®Google Scholar
• Solomon VR, Haq W, Smilkstein M, Srivastava K, Rajakumar S, Puri SK et al. Synthesis and antimalarial activity of novel side chain modified antimalarial agents derived from 4-aminoquinoline. Med Chem 2008;4:446–456.
   PubMedGoogle Scholar
• Solomon VR, Puri SK, Srivastava K, Katti SB. Design and synthesis of new antimalarial agents from 4-aminoquinoline. Bioorg Med Chem 2005;13:2157–2165.
   PubMed Web of Science ®Google Scholar
• Solomon VR, Haq W, Srivastava K, Puri SK, Katti SB. Synthesis and antimalarial activity of side chain modified 4-aminoquinoline derivatives. J Med Chem 2007;50:394–398.
   PubMed Web of Science ®Google Scholar
• Solomon VR, Haq W, Puri SK, Srivastava K, Katti SB. Design, Synthesis of 4-aminoquinoline derived thiazolidines and their antimalarial activity and heme polymerization inhibition studies. J Enzyme Inhib Med Chem 2012; Manuscript accepted for publication. Please cite doi:10.3109/14756366.2012.666537.
   Google Scholar
• Elsager EF, Gold EH, Tendick FH, Werbel LM, Worth DF. Amodiaquine N-oxides and other 7-chloro-4-aminoquinoline n-oxides. J Heterocycl Chem 1964;1:6–12.
   Google Scholar
• Trager W, Jensen JB. Human malaria parasites in continuous culture. Science 1976;193:673–675.
   PubMed Web of Science ®Google Scholar
• Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 1979;65:418–420.
   PubMed Web of Science ®Google Scholar
• Srivastava K, Puri SK. Plasmodium falciparum: modified medium composition supports continuous cultivation with foetal bovine serum. Exp Parasitol 2004;108:74–75.
   PubMedGoogle Scholar
• Puri SK, Singh N. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys. Exp Parasitol 2000;94:8–14.
   PubMedGoogle Scholar
• Diggens SM, Gregory K. Comparative response of various rodent malarias to chemotherapy. Trans R Soc Trop Med Hyg 1969;63:7.
   PubMed Web of Science ®Google Scholar
• Egan TJ, Mavuso WW, Ross DC, Marques HM. Thermodynamic factors controlling the interaction of quinoline antimalarial drugs with ferriprotoporphyrin IX. J Inorg Biochem 1997;68:137–145.
   PubMed Web of Science ®Google Scholar
• Tripathi AK, Khan SI, Walker LA, Tekwani BL. Spectrophotometric determination of de novo hemozoin/beta-hematin formation in an in vitro assay. Anal Biochem 2004;325:85–91.
   PubMed Web of Science ®Google Scholar
• GraphPad Prism, version 4.0b, GraphPad Software Inc., 10855 Sorrento Valley Rd. #203, San Diego, CA 92121, 2007.
   Google Scholar
• Egan TJ, Hunter R, Kaschula CH, Marques HM, Misplon A, Walden J. Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of beta-hematin formation, and antiplasmodial activity. J Med Chem 2000;43:283–291.
   PubMed Web of Science ®Google Scholar
• Kaschula CH, Egan TJ, Hunter R, Basilico N, Parapini S, Taramelli D et al. Structure-activity relationships in 4-aminoquinoline antiplasmodials. The role of the group at the 7-position. J Med Chem 2002;45:3531–3539.
   PubMed Web of Science ®Google Scholar
• Egan TJ. Hemozoin (malaria pigement): A Unique Crystalline Drug Target. Targets 2003;3:115–124.
   Google Scholar
• Dorn A, Vippagunta SR, Matile H, Jaquet C, Vennerstrom JL, Ridley RG. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem Pharmacol 1998;55:727–736.
   PubMed Web of Science ®Google Scholar
• Vippagunta SR, Dorn A, Matile H, Bhattacharjee AK, Karle JM, Ellis WY et al. Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerization and parasite growth. J Med Chem 1999;42:4630–4639.
   PubMed Web of Science ®Google Scholar
• Vippagunta SR, Dorn A, Ridley RG, Vennerstrom JL. Characterization of chloroquine-hematin mu-oxo dimer binding by isothermal titration calorimetry. Biochim Biophys Acta 2000;1475:133–140.
   PubMed Web of Science ®Google Scholar
• Pallas 3.0, Compu-Drug Chemistry, Ltd., San Francisco, CA, 1984.
   Google Scholar